This story originally ran on Feb. 1.

Thermo Fisher Scientific this week reported $3.13 billion in Q4 2011 revenues, up 15 percent from $2.72 billion in Q4 2010 and beating Wall Street estimates of $3.08 billion.

On a conference call to discuss the financial results, president and CEO Marc Casper highlighted the launch of new products, including the Q Exactive mass spectrometer, as a "key aspect" of the company's revenue growth.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.